We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+0.89%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$5.29B
AUM Growth
–
Cap. Flow
+$5.37B
Cap. Flow %
101.51%
Top 10 Hldgs %
28.42%
Holding
359
New
359
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$330M
2
JNJ icon
Johnson & Johnson
JNJ
+$164M
3
MCD icon
McDonald's
MCD
+$164M
4
CVX icon
Chevron
CVX
+$132M
5
INTC icon
Intel
INTC
+$129M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 16.23%
2 Technology 15.85%
3 Healthcare 14.87%
4 Energy 12.34%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PX
26
DELISTED
Praxair Inc
PX
$69.2M 1.31%
+600,832
New +$68.4M
ACN icon
27
Accenture
ACN
$102B
$66.6M 1.26%
+925,139
New +$73.5M
ABBV icon
28
AbbVie
ABBV
$443B
$64.6M 1.22%
+1,561,746
New +$68.3M
ADI icon
29
Analog Devices
ADI
$179B
$63M 1.19%
+1,398,941
New +$63M
BLK icon
30
Blackrock
BLK
$169B
$63M 1.19%
+245,181
New +$65.7M
GPC icon
31
Genuine Parts
GPC
$17.1B
$56.2M 1.06%
+720,073
New +$55.9M
BMY icon
32
Bristol-Myers Squibb
BMY
$133B
$54.6M 1.03%
+1,222,496
New +$53.1M
ABT icon
33
Abbott
ABT
$183B
$54M 1.02%
+1,547,426
New +$56.8M
WELL icon
34
Welltower
WELL
$169B
$53.3M 1.01%
+794,875
New +$56.5M
AMGN icon
35
Amgen
AMGN
$208B
$51M 0.96%
+517,284
New +$53.7M
DIS icon
36
Walt Disney
DIS
$167B
$49.6M 0.94%
+785,850
New +$49.6M
DOC icon
37
Healthpeak Properties
DOC
$15.1B
$49.6M 0.94%
+1,198,751
New +$54.7M
SYK icon
38
Stryker
SYK
$125B
$48.4M 0.91%
+747,784
New +$49.6M
SO icon
39
Southern Company
SO
$109B
$47.9M 0.91%
+1,085,218
New +$49.9M
CFR icon
40
Cullen/Frost Bankers
CFR
$10.4B
$46.2M 0.87%
+691,275
New +$43.6M
DOV icon
41
Dover
DOV
$27.6B
$44.6M 0.84%
+856,916
New +$42.9M
BNS icon
42
Scotiabank
BNS
$107B
$43.6M 0.82%
+875,564
New +$46M
BAX icon
43
Baxter International
BAX
$13.5B
$43.4M 0.82%
+1,153,416
New +$44.2M
NEE icon
44
NextEra Energy
NEE
$181B
$43M 0.81%
+2,112,700
New +$41.9M
ECL icon
45
Ecolab
ECL
$78.1B
$42.2M 0.8%
+495,013
New +$41.8M
T icon
46
AT&T
T
$159B
$42.1M 0.8%
+1,574,952
New +$43.8M
GSK icon
47
GSK
GSK
$104B
$40.7M 0.77%
+651,830
New +$41.4M
BDX icon
48
Becton Dickinson
BDX
$45.6B
$40M 0.76%
+415,352
New +$39.6M
BCE icon
49
BCE
BCE
$20.2B
$39.7M 0.75%
+966,977
New +$43.8M
MO icon
50
Altria Group
MO
$114B
$39.5M 0.75%
+1,128,578
New +$40.5M
1
2
3 4 5

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Bahl & Gaynor, which disclosed 359 positions worth $5.29B. Its ten largest holdings account for 28% of the portfolio.

Its largest position is Procter & Gamble: 4,199,813 shares worth $323M.

By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, followed by Technology and Healthcare.

  • Bahl & Gaynor's largest Q2 2013 buy was Procter & Gamble: 4,199,813 shares worth $323M.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $5.29B portfolio in Q2 2013.
  • Bahl & Gaynor disclosed 359 positions in Q2 2013, its first 13F filing on record.

Based on Bahl & Gaynor's 13F filing for Q2 2013, filed 16 Aug 2013.